Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors
Raskin N, Hiligsmann M, Rebutoc A, Bansback N, Boonen A, Buchbinder R, Falahee M, Fraenkel L, Marshall D, Maxwell L, Nieuwlaat R, Proulx L, Saadat P, Shea B, Tugwell P, Wiercioch W, Beaton D, Richards P, Schünemann H, Guillemin F, Hazlewood G. Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors. Seminars In Arthritis And Rheumatism 2025, 74: 152769. PMID: 40544704, DOI: 10.1016/j.semarthrit.2025.152769.Peer-Reviewed Original ResearchHealth outcome descriptorsPatient decision aidsHealth outcomesPatient-important outcomesPatient preference studiesOutcome descriptorsThematic content analysisOutcome descriptionsNarrative summaryPreference studiesPtDAsRA outcomesAuthor consensusRheumatoid arthritisData extractionModifying drug therapySymptoms patientsContent analysisAdverse eventsDrug therapyDisease modifying drug therapyLack of descriptionHealthOutcomesAIDS
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply